Board Meeting On September 14, 2017
Pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and as per the terms of 'Code of Conduct Insider Trading' of the Company, the trading window shall be closed from September 08, 2017 and re-opens on September 17, 2017.The communication has been circulated to all Directors, Officers and Designated Employees of the Company. Board Meeting On September 14, 2017
Pursuant to the provisions of Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, September 14, 2017, inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2017. Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Gufic Biosciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Outcome of AGM
Outcome of the 33rd Annual General Meeting of the Company held on Tuesday, September 05,2017 at 2.30 P.M. Fixes Book Closure for Dividend & AGM (Cut-off date for e-voting)
Gufic Biosciences Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from August 30, 2017 to September 05, 2017 (both days inclusive) for the purpose of Payment of Dividend & 33rd Annual General Meeting (AGM) of the Company to be held on September 05, 2017. Fixes Book Closure For The Purpose Of 33Rd Annual General Meeting And Payment Of Dividend For Financial Year 2016-17
This is to inform you that the Register of Members and the Share Transfer Books will remain close from Wednesday, August 30, 2017 to Tuesday, September 05, 2017 (both days inclusive) for the purpose of AGM to be held on September 05, 2017 and determining the persons entitled for dividend for the year ended March 31, 2017. Further, the Company is providing to its Members, facility to exercise their right to vote on resolutions proposed to... Re-Submission Of Audited Financial Results For The Quarter And Year Ended March 31, 2017 , As Per Schedule III Of The Companies Act, 2013 Along With The Statement Of Impact Of Qualification
With reference, to the mail dated July 10, 2017 received by the Exchange with regards to submission of Financial results as per Schedule III of the Companies Act, 2013 and Statement of Impact of Qualification by the Company, enclosed is the same, for records. Shareholding for the Period Ended June 30, 2017
Gufic Biosciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here Statement Of Investor Complaints For The Quarter Ended June 30, 2017
The Company did not receive any investor complaints during the quarter ended June 30, 2017